SCHEMBL25377441

SCHEMBL25377441

FC(F)(F)c1ccc(Nc2nccnc2-c2cnc(Cl)nc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 12/20 0.47
▸ TRPV1 Q8NER1 7/20 0.46
▸ CTSC P53634 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30482543 1.00 EPHX2 (0.47) EPHX2TRPV1CTSC
SCHEMBL25378382 0.86 KCNQ3 (0.47) EPHX2TRPV1CTSC
SCHEMBL30482575 0.86 KCNQ3 (0.47) EPHX2TRPV1CTSC
SCHEMBL30482518 0.86 TRPV1 (0.46) EPHX2TRPV1
SCHEMBL25377909 0.86 TRPV1 (0.46) EPHX2TRPV1
SCHEMBL25377798 0.83 TRPV1 (0.46) EPHX2TRPV1
SCHEMBL25378159 0.83 TRPV1 (0.43) EPHX2TRPV1
SCHEMBL25378719 0.81 TRPV1 (0.42) EPHX2TRPV1
SCHEMBL25340913 0.80 KIF11 (0.51) EPHX2TRPV1
SCHEMBL30519339 0.80 KIF11 (0.51) EPHX2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146512-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146512-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback